Our top pick for
Building a portfolio
Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
Independence Holding Company is an insurance-life business based in the US. Independence Holding Company shares (IHC) are listed on the NYSE and all prices are listed in US Dollars. Independence Holding Company employs 455 staff and has a trailing 12-month revenue of around USD$408.7 million.
|Latest market close||USD$38.09|
|52-week range||USD$21.7135 - USD$43.1865|
|50-day moving average||USD$40.4336|
|200-day moving average||USD$36.3011|
|Wall St. target price||USD$17.5|
|Dividend yield||USD$0.44 (1.1%)|
|Earnings per share (TTM)||USD$0.271|
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-01-14)||-9.95%|
|1 month (2020-12-22)||-4.92%|
|3 months (2020-10-21)||-6.48%|
|6 months (2020-07-21)||15.46%|
|1 year (2020-01-21)||-8.70%|
|2 years (2019-01-18)||5.81%|
|3 years (2018-01-19)||36.77%|
|5 years (2016-01-21)||174.03%|
Valuing Independence Holding Company stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Independence Holding Company's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Independence Holding Company's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 148x. In other words, Independence Holding Company shares trade at around 148x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Independence Holding Company's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$13.8 million.
The EBITDA is a measure of a Independence Holding Company's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||USD$408.7 million|
|Operating margin TTM||2.37%|
|Gross profit TTM||USD$200.3 million|
|Return on assets TTM||0.56%|
|Return on equity TTM||0.91%|
|Market capitalisation||USD$586.2 million|
TTM: trailing 12 months
There are currently 59,612 Independence Holding Company shares held short by investors – that's known as Independence Holding Company's "short interest". This figure is 9.4% down from 65,816 last month.
There are a few different ways that this level of interest in shorting Independence Holding Company shares can be evaluated.
Independence Holding Company's "short interest ratio" (SIR) is the quantity of Independence Holding Company shares currently shorted divided by the average quantity of Independence Holding Company shares traded daily (recently around 6713.0630630631). Independence Holding Company's SIR currently stands at 8.88. In other words for every 100,000 Independence Holding Company shares traded daily on the market, roughly 8880 shares are currently held short.
However Independence Holding Company's short interest can also be evaluated against the total number of Independence Holding Company shares, or, against the total number of tradable Independence Holding Company shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Independence Holding Company's short interest could be expressed as 0% of the outstanding shares (for every 100,000 Independence Holding Company shares in existence, roughly 0 shares are currently held short) or 0.0126% of the tradable shares (for every 100,000 tradable Independence Holding Company shares, roughly 13 shares are currently held short).
A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Independence Holding Company.
Find out more about how you can short Independence Holding Company stock.
Dividend payout ratio: 42.76% of net profits
Recently Independence Holding Company has paid out, on average, around 42.76% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 1.1% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Independence Holding Company shareholders could enjoy a 1.1% return on their shares, in the form of dividend payments. In Independence Holding Company's case, that would currently equate to about $0.44 per share.
While Independence Holding Company's payout ratio might seem fairly standard, it's worth remembering that Independence Holding Company may be investing much of the rest of its net profits in future growth.
Independence Holding Company's most recent dividend payout was on 7 January 2021. The latest dividend was paid out to all shareholders who bought their shares by 23 December 2020 (the "ex-dividend date").
Independence Holding Company's shares were split on 15 February 2012.
Over the last 12 months, Independence Holding Company's shares have ranged in value from as little as $21.7135 up to $43.1865. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Independence Holding Company's is 0.7349. This would suggest that Independence Holding Company's shares are less volatile than average (for this exchange).
Independence Holding Company, through its subsidiaries, engages in life and health insurance business. The company's dental portfolio includes indemnity and PPO plans for employer groups of two or more lives, and for individuals within affinity groups; vision plans that offer a flat reimbursement amount for exams and materials; and short-term medical products for people with temporary needs for health coverage. It also provides supplemental products, including hospital indemnity, fixed indemnity limited benefit, critical illness, accident medical coverage, and life insurance products to individuals and families; and pet insurance and occupational accident insurance products. In addition, the company offers group long-term and short-term disability products to employers that provide benefit to their employees; New York short-term disability plan that offers temporary cash payments to replace wages lost; and group term life products, such as group term life, accidental death and dismemberment (AD&D), supplemental life and AD&D, and dependent life products. Independence Holding Company markets its products through general agents, independent brokers, and independent producers in 50 states of the United States, the District of Columbia, the Virgin Islands, and Puerto Rico. The company was founded in 1980 and is headquartered in Stamford, Connecticut.
Everything we know about the NLS Pharmaceutics Ltd IPO, plus information on how to buy in.
Everything we know about the GitLab IPO, plus information on how to buy in.
Everything we know about the Longeveron LLC IPO, plus information on how to buy in.
Everything we know about the Signify Health Inc IPO, plus information on how to buy in.
Everything we know about the Biophytis SA IPO, plus information on how to buy in.
Everything we know about the NexImmune Inc IPO, plus information on how to buy in.
Everything we know about the Adagene Inc IPO, plus information on how to buy in.
Everything we know about the Cloopen Group Holding Limited IPO, plus information on how to buy in.
Everything we know about the Decipher Biosciences Inc IPO, plus information on how to buy in.
Everything we know about the Proterra IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.